Cerebellar Granule Cells in Ataxia-Telangiectasia <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Cerebellar Granule Cells in Ataxia-Telangiectasia</th> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0000120](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000120)</td> </tr> <tr> <td class="label">Feature</td> <td>Details</td> </tr> <tr> <td class="label">Gene location</td> <td>Chromosome 11q22-23</td> </tr> <tr> <td class="label">Protein</td> <td>ATM kinase (350 kDa)</td> </tr> <tr> <td class="label">Function</td> <td>DNA double-strand break repair</td> </tr> <tr> <td class="label">Inheritance</td> <td>Autosomal recessive</td> </tr> <tr> <td class="label">Mutation types</td> <td>Nonsense, missense, frameshift, splicing</td> </tr> <tr> <td class="label">System</td> <td>Manifestation</td> </tr> <tr> <td class="label">Neurological</td> <td>Cerebellar ataxia</td> </tr> <tr> <td class="label">Immunological</td> <td>Recurrent infections</td> </tr> <tr> <td class="label">Cutaneous</td> <td>Telangiectasias</td> </tr> <tr> <td class="label">Endocrine</td> <td>Diabetes, growth delay</td> </tr> <tr> <td class="label">Oncological</td> <td>Cancer predisposition</td> </tr> <tr> <td class="label">Number</td> <td>Most abundant neurons in brain (~10^
...
Cerebellar Granule Cells in Ataxia-Telangiectasia <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Cerebellar Granule Cells in Ataxia-Telangiectasia</th> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0000120](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000120)</td> </tr> <tr> <td class="label">Feature</td> <td>Details</td> </tr> <tr> <td class="label">Gene location</td> <td>Chromosome 11q22-23</td> </tr> <tr> <td class="label">Protein</td> <td>ATM kinase (350 kDa)</td> </tr> <tr> <td class="label">Function</td> <td>DNA double-strand break repair</td> </tr> <tr> <td class="label">Inheritance</td> <td>Autosomal recessive</td> </tr> <tr> <td class="label">Mutation types</td> <td>Nonsense, missense, frameshift, splicing</td> </tr> <tr> <td class="label">System</td> <td>Manifestation</td> </tr> <tr> <td class="label">Neurological</td> <td>Cerebellar ataxia</td> </tr> <tr> <td class="label">Immunological</td> <td>Recurrent infections</td> </tr> <tr> <td class="label">Cutaneous</td> <td>Telangiectasias</td> </tr> <tr> <td class="label">Endocrine</td> <td>Diabetes, growth delay</td> </tr> <tr> <td class="label">Oncological</td> <td>Cancer predisposition</td> </tr> <tr> <td class="label">Number</td> <td>Most abundant neurons in brain (~10^11)</td> </tr> <tr> <td class="label">Location</td> <td>Cerebellar granular layer</td> </tr> <tr> <td class="label">Input</td> <td>Mossy fibers</td> </tr> <tr> <td class="label">Output</td> <td>Parallel fibers to molecular layer</td> </tr> <tr> <td class="label">Neurotransmitter</td> <td>Glutamate</td> </tr> <tr> <td class="label">Target</td> <td>Purkinje cell dendrites</td> </tr> <tr> <td class="label">Step</td> <td>ATM Target</td> </tr> <tr> <td class="label">Detection</td> <td>MRN complex</td> </tr> <tr> <td class="label">Signaling</td> <td>ATM autophosphorylation</td> </tr> <tr> <td class="label">Chromatin</td> <td>H2AX (γ-H2AX)</td> </tr> <tr> <td class="label">Cell cycle</td> <td>p53, CHK2</td> </tr> <tr> <td class="label">Repair</td> <td>BRCA1, NBS1</td> </tr> <tr> <td class="label">Target</td> <td>Damage Type</td> </tr> <tr> <td class="label">DNA</td> <td>8-oxo-guanine</td> </tr> <tr> <td class="label">Lipids</td> <td>Lipid peroxidation</td> </tr> <tr> <td class="label">Proteins</td> <td>Carbonylation</td> </tr> <tr> <td class="label">Mitochondria</td> <td>mtDNA damage</td> </tr> <tr> <td class="label">Cell Type</td> <td>A-T Changes</td> </tr> <tr> <td class="label">Granule cells</td> <td>Marked loss, especially vermis</td> </tr> <tr> <td class="label">Purkinje cells</td> <td>Dendritic atrophy, reduced density</td> </tr> <tr> <td class="label">Basket cells</td> <td>Relatively preserved</td> </tr> <tr> <td class="label">Golgi cells</td> <td>Variable loss</td> </tr> <tr> <td class="label">Molecular layer</td> <td>Thinned</td> </tr> <tr> <td class="label">Feature</td> <td>Age of Onset</td> </tr> <tr> <td class="label">Gait ataxia</td> <td>1-2 years</td> </tr> <tr> <td class="label">Dysarthria</td> <td>3-5 years</td> </tr> <tr> <td class="label">Oculomotor apraxia</td> <td>2-4 years</td> </tr> <tr> <td class="label">Choreoathetosis</td> <td>5-10 years</td> </tr> <tr> <td class="label">Peripheral neuropathy</td> <td>Teens</td> </tr> <tr> <td class="label">Intervention</td> <td>Target</td> </tr> <tr> <td class="label">Physical therapy</td> <td>Motor function</td> </tr> <tr> <td class="label">Speech therapy</td> <td>Communication</td> </tr> <tr> <td class="label">Immunoglobulin</td> <td>Infection prevention</td> </tr> <tr> <td class="label">Antioxidants</td> <td>Oxidative stress</td> </tr> <tr> <td class="label">Approach</td> <td>Mechanism</td> </tr> <tr> <td class="label">Read-through compounds</td> <td>Nonsense mutation bypass</td> </tr> <tr> <td class="label">ATMi inhibitors</td> <td>Modulate ATM pathway</td> </tr> <tr> <td class="label">Neuroprotective agents</td> <td>Reduce granule cell death</td> </tr> <tr> <td class="label">Stem cell therapy</td> <td>Replace lost cells</td> </tr> <tr> <td class="label">Disorder</td> <td>Shared Features</td> </tr> <tr> <td class="label">Alzheimer disease</td> <td>Oxidative stress, DNA damage</td> </tr> <tr> <td class="label">Parkinson disease</td> <td>Mitochondrial dysfunction</td> </tr> <tr> <td class="label">ALS</td> <td>Impaired DNA repair</td> </tr> <tr> <td class="label">Spinocerebellar ataxias</td> <td>Cerebellar degeneration</td> </tr> </table>
Overview Ataxia-telangiectasia (A-T) is a rare autosomal recessive neurodegenerative disorder caused by mutations in the ATM (ataxia-telangiectasia mutated) gene. Cerebellar granule cells are particularly vulnerable to ATM deficiency, leading to progressive cerebellar degeneration and ataxia. Understanding the molecular mechanisms of granule cell vulnerability in A-T provides insights into DNA damage responses, oxidative stress, and potential therapeutic strategies for broader neurodegenerative contexts.
Mermaid diagram (expand to render)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
[Cell Ontology (CL:0000120)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000120)
[OBO Foundry (CL:0000120)](http://purl.obolibrary.org/obo/CL_0000120)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
Ataxia-Telangiectasia Pathophysiology
Genetic Basis The ATM gene encodes a serine/threonine protein kinase central to DNA damage response:
ATM Functions in Neurons
DNA double-strand break repair : Phosphorylates H2AX, p53, BRCA1
Oxidative stress response : Activates antioxidant pathways
Cell cycle checkpoint : G1/S and G2/M arrest
Mitochondrial homeostasis : Regulates mitophagy
Synaptic function : DNA repair during activity-dependent transcription
Systemic Features of A-T
Cerebellar Granule Cell Vulnerability
Why Granule Cells Are Affected Cerebellar granule cells exhibit unique susceptibility to ATM deficiency:
High metabolic demand : Dense synaptic connections requiring ATP
Continuous firing : High action potential frequency (50-200 Hz)
Glutamate sensitivity : Excitotoxicity risk
Oxidative metabolism : High ROS production
Limited antioxidant capacity : Reduced glutathione stores
DNA replication stress : During development
Granule Cell Biology
Molecular Changes in A-T Granule Cells
Mermaid diagram (expand to render)
DNA Damage Response in Neurons
Double-Strand Break Repair Neurons accumulate DNA damage throughout life due to:
Oxidative stress : Endogenous ROS from metabolism
Transcriptional stress : Activity-induced DNA breaks
Developmental processes : Neurogenesis and migration
Environmental factors : Radiation, toxins
Failure Consequences Without functional ATM:
Persistent DNA breaks : Unrepaired double-strand breaks
Chromosomal aberrations : Translocations, deletions
Transcriptional blocks : Stalled RNA polymerase
Apoptosis : p53-mediated cell death
Oxidative Stress Mechanism
Sources of ROS in Granule Cells
Mitochondrial respiration : ETC electron leak
Glutamate receptor activation : NMDA-mediated Ca2+ influx
Dopamine oxidation : In cerebellar connections
Inflammatory response : Microglial activation
ATM as Redox Sensor
Cytosolic ATM : Responds to oxidative stress
Disulfide bond formation : Activates ATM dimers
PERK pathway : Regulates ER stress response
Nrf2 activation : Antioxidant gene expression
Oxidative Damage in A-T
Neurodegeneration Cascade
Progressive Cerebellar Atrophy A-T shows characteristic cerebellar changes:
Early changes : Granule cell loss in vermis
Progression : Purkinje cell dendritic atrophy
Advanced disease : Global cerebellar atrophy
White matter : Reduced cerebellar peduncles
Temporal Progression
Mermaid diagram (expand to render)
Histopathological Findings
Clinical Features
Neurological Manifestations
Cerebellar Signs
Truncal ataxia : Wide-based gait, frequent falls
Limb ataxia : Dysmetria, intention tremor
Dysarthria : Scanning speech pattern
Oculomotor abnormalities : Saccadic pursuit, apraxia
Therapeutic Approaches
Current Management
Experimental Therapies
ATM kinase activators : Small molecule restoration
Gene therapy : AAV-mediated ATM delivery
Antioxidant cocktails : N-acetylcysteine, vitamin E
DNA repair enhancement : PARP activators
Research Directions
Broader Relevance to Neurodegeneration
DNA Damage in Aging Brain A-T provides insights into:
Aging-associated DNA damage : Accumulating DSBs
Oxidative stress vulnerability : Common pathway in AD, PD
Genomic instability : Cancer and neurodegeneration link
Overlap with Other Disorders
Clinical Assessment
Diagnostic Criteria
Clinical : Progressive cerebellar ataxia before age 5
Oculomotor : Oculomotor apraxia
Telangiectasias : Conjunctival or cutaneous
Immunological : Low IgA, IgG, or IgM
Laboratory : Elevated α-fetoprotein
Genetic : Biallelic ATM mutations
Neuroimaging
MRI cerebellum : Progressive atrophy
Vermis : Early involvement
Cerebral white matter : Variable changes
Spinal cord : Occasional atrophy
[Neurons](/cell-types/neurons) Major brain cell type
Glia — Suppor- [Alzheimer's Disease](/diseases/alzheimers-disease)Alzhe- [Parkinson's Disease](/diseases/parkinsons-disease)d neurodegenerative disease
[Parkinson's Disease](/diseases/parkinsons-disease) Related neurodegenerative disease
External Links
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
Show full description